Literature DB >> 2547218

Urocanic acid analogues and the suppression of the delayed type hypersensitivity response to Herpes simplex virus.

M Norval, T J Simpson, E Bardshiri, S E Howie.   

Abstract

Ultraviolet irradiated urocanic acid (4-imidazoleacrylic acid) containing a mixture of cis- and trans-isomers has been shown previously to induce suppression of the delayed type hypersensitivity (DTH) response to Herpes simplex virus type 1 (HSV-1) in a murine model of infection. The cis-isomer of urocanic acid was prepared and the cis- and trans-isomers of 2-methylurocanic acid. 2-pyrroleacrylic acid, 2-furanacrylic acid, 2-thiopheneacrylic acid, 3-thiopheneacrylic acid as well as dihydrourocanic acid and histamine. Each was applied at concentrations of 1 and 50 micrograms per mouse to the shaved dorsal skin and the mice were infected subcutaneously with HSV 5 h later. After 8-10 days the DTH response to the virus was measured by an ear swelling test. It was found that cis-urocanic acid was effective in suppressing the DTH response at levels of 1 microgram per mouse or less. The cis- and trans-isomers of 2-furanacrylic acid, 2-pyrroleacrylic acid and 2-thiopheneacrylic acid were also effective, with the cis- form generally being more active than trans, and 2-pyrroleacrylic acid being particularly potent. Cis- and trans-3-thiopheneacrylic acid, on the other hand, were only marginally immunosuppressive while neither isomer of 2-methylurocanic acid had any suppressive ability. Dihydrourocanic acid and histamine were also shown to suppress the DTH response. Thus the structural features necessary for urocanic acid and its analogues to act as mediators of UV-induced immunosuppression could be deduced and implications for their mechanism of action discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547218     DOI: 10.1111/j.1751-1097.1989.tb08435.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  8 in total

1.  Epidermal trans-urocanic acid and the UV-A-induced photoaging of the skin.

Authors:  K M Hanson; J D Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

2.  The role of interleukin-4 in ultraviolet B light-induced immunosuppression.

Authors:  A A el-Ghorr; M Norval
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

3.  Carnosine (beta-alanylhistidine) protects from the suppression of contact hypersensitivity by ultraviolet B (280-320 nm) radiation or by cis urocanic acid.

Authors:  V E Reeve; M Bosnic; E Rozinova
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

4.  Expression of CD80 (B7/BB-1) and CD28 in human white blood cells treated with urocanic acid.

Authors:  J K Laihia; J Uksila; M Luhtala; C T Jansén
Journal:  Arch Dermatol Res       Date:  1996-09       Impact factor: 3.017

5.  Characterization of a monoclonal antibody to cis-urocanic acid: detection of cis-urocanic acid in the serum of irradiated mice by immunoassay.

Authors:  A M Moodycliffe; M Norval; I Kimber; T J Simpson
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

6.  The effect of ultraviolet B irradiation and urocanic acid isomers on dendritic cell migration.

Authors:  A M Moodycliffe; I Kimber; M Norval
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

7.  Localization of DNA damage and its role in altered antigen-presenting cell function in ultraviolet-irradiated mice.

Authors:  A A Vink; F M Strickland; C Bucana; P A Cox; L Roza; D B Yarosh; M L Kripke
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

8.  Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells.

Authors:  Claire S Leitch; Eenass Natafji; Cunjing Yu; Sharizan Abdul-Ghaffar; Nayani Madarasingha; Zoë C Venables; Roland Chu; Paul M Fitch; Andrew J Muinonen-Martin; Linda E Campbell; W H Irwin McLean; Jürgen Schwarze; Sarah E M Howie; Richard B Weller
Journal:  J Allergy Clin Immunol       Date:  2016-03-02       Impact factor: 10.793

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.